Deutsche Bank AG Sells 9,774 Shares of Simulations Plus, Inc. (SLP)

Share on StockTwits

Deutsche Bank AG trimmed its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 38.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,797 shares of the technology company’s stock after selling 9,774 shares during the quarter. Deutsche Bank AG’s holdings in Simulations Plus were worth $312,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the company. Advisor Group Inc. boosted its stake in shares of Simulations Plus by 156.9% during the fourth quarter. Advisor Group Inc. now owns 2,112 shares of the technology company’s stock valued at $42,000 after purchasing an additional 1,290 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of Simulations Plus by 8.6% in the fourth quarter. Bessemer Group Inc. now owns 31,700 shares of the technology company’s stock worth $631,000 after acquiring an additional 2,500 shares during the period. Martingale Asset Management L P lifted its stake in shares of Simulations Plus by 4.7% in the fourth quarter. Martingale Asset Management L P now owns 73,608 shares of the technology company’s stock worth $1,465,000 after acquiring an additional 3,300 shares during the period. Bank of America Corp DE lifted its stake in shares of Simulations Plus by 65.7% in the fourth quarter. Bank of America Corp DE now owns 8,754 shares of the technology company’s stock worth $174,000 after acquiring an additional 3,471 shares during the period. Finally, Algert Global LLC lifted its stake in shares of Simulations Plus by 19.0% in the fourth quarter. Algert Global LLC now owns 23,522 shares of the technology company’s stock worth $468,000 after acquiring an additional 3,762 shares during the period. 41.90% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms recently commented on SLP. BidaskClub raised Simulations Plus from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 22nd. Zacks Investment Research raised Simulations Plus from a “hold” rating to a “buy” rating and set a $27.00 price objective on the stock in a research note on Saturday, May 11th.

Simulations Plus stock opened at $25.04 on Monday. The company has a market capitalization of $438.58 million, a P/E ratio of 50.08 and a beta of -0.47. Simulations Plus, Inc. has a one year low of $16.70 and a one year high of $26.10.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Tuesday, April 9th. The technology company reported $0.12 EPS for the quarter, topping the Zacks’ consensus estimate of $0.10 by $0.02. The company had revenue of $8.47 million for the quarter, compared to analyst estimates of $8.10 million. Simulations Plus had a return on equity of 22.87% and a net margin of 23.61%. Analysts predict that Simulations Plus, Inc. will post 0.44 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Wednesday, April 24th were issued a $0.06 dividend. The ex-dividend date was Tuesday, April 23rd. This represents a $0.24 dividend on an annualized basis and a yield of 0.96%. Simulations Plus’s payout ratio is currently 48.00%.

In other Simulations Plus news, Director Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction that occurred on Tuesday, February 26th. The stock was sold at an average price of $20.65, for a total value of $382,025.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David L. Ralph sold 3,000 shares of Simulations Plus stock in a transaction that occurred on Friday, April 12th. The stock was sold at an average price of $22.74, for a total value of $68,220.00. Following the completion of the sale, the director now owns 18,006 shares of the company’s stock, valued at $409,456.44. The disclosure for this sale can be found here. Over the last quarter, insiders sold 58,500 shares of company stock valued at $1,241,120. 31.57% of the stock is currently owned by corporate insiders.

WARNING: This piece of content was reported by Zolmax and is owned by of Zolmax. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://zolmax.com/investing/deutsche-bank-ag-sells-9774-shares-of-simulations-plus-inc-slp/3096528.html.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Recommended Story: Why is the ROA ratio important?

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Goldman Sachs BDC Inc  Receives Average Recommendation of “Hold” from Brokerages
Goldman Sachs BDC Inc Receives Average Recommendation of “Hold” from Brokerages
Analysts Set Daily Mail and General Trust P L C  Price Target at $685.57
Analysts Set Daily Mail and General Trust P L C Price Target at $685.57
Novocure Ltd  Receives $52.00 Consensus Target Price from Brokerages
Novocure Ltd Receives $52.00 Consensus Target Price from Brokerages
PetIQ Inc  Given Average Rating of “Buy” by Analysts
PetIQ Inc Given Average Rating of “Buy” by Analysts
Banco Santander SA  Receives Average Recommendation of “Buy” from Brokerages
Banco Santander SA Receives Average Recommendation of “Buy” from Brokerages
Precision Drilling Corp  Receives Average Recommendation of “Buy” from Analysts
Precision Drilling Corp Receives Average Recommendation of “Buy” from Analysts


 
© 2006-2019 Zolmax.